Nicholas N. Vahanian

Nessuna posizione attualmente

56 anni

Health Technology

Consumer Services

Profilo

Nicholas N.
Vahanian was the founder who founded NewLink Genetics Corp.
in 1999 and held the titles of President, Director & Chief Medical Officer from 2015 to 2017.
He also worked as President at Lumos Pharma, Inc. in a former job.
Dr. Vahanian earned an MBA degree from the University of Notre Dame and an undergraduate degree from Virginia Commonwealth University.

Precedenti posizioni note di Nicholas N. Vahanian

Società	Posizione	Fine
LUMOS PHARMA, INC.	Fondatore	11/11/2019
LUMOS PHARMA, INC.	Presidente	27/09/2019

Vedi nel dettaglio l'esperienza di Nicholas N. Vahanian

Formazione di Nicholas N. Vahanian

Virginia Commonwealth University	Undergraduate Degree
University of Notre Dame	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Nicholas N. Vahanian

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
LUMOS PHARMA, INC.	Health Technology

Aziende private	1
NewLink Genetics Corp. NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA.	Health Technology